Mucosal tolerance to E-selectin and response to systemic inflammation

Journal of Cerebral Blood Flow and Metabolism

Volumn 26, Issue 12, 2006, Pages 1538-1550

  Illoh, Kachi ^a   Campbell, Catherine ^b   Illoh, Orieji ^a   Diehl, John ^c   Cherry, James ^c   Elkhaloun, Abdel ^d   Chen, Yong ^b   Hallenbeck, John ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

E selectin; Gene expression; Immune tolerance; Inflammation

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SOMATOMEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; BRAIN; CELL PROTECTION; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; MUCOSAL IMMUNITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN; SPONTANEOUSLY HYPERTENSIVE RAT;

ANIMALS; ANTIBODY FORMATION; BRAIN; BRAIN INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; E-SELECTIN; GENE EXPRESSION REGULATION; IMMUNE TOLERANCE; IMMUNOGLOBULIN G; INFLAMMATION; LIPOPOLYSACCHARIDES; NASAL MUCOSA; ORGAN SPECIFICITY; RATS; RATS, INBRED SHR; SPLEEN;

EID: 33751330159     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600308     Document Type: Article

References (39)

1. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to MBP decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad Sci USA 94:10873-8
2. Beilharz EJ, Bassett NS, Sirimanne ES, Williams CE, Gluckman PD (1995) Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain. Brain Res Mol Brain Res 29:81-91
3. Blumberg RS (1998) Current concepts in mucosal immunity. II. One size fits all: nonclassical MHC molecules fulfill multiple roles in epithelial cell function. Am J Physiol 274:G227-31
4. Bogumil T, Rieckmann P, Kubuschok B, Felgenhauer K, Bruck W (1998) Serum levels of macrophage-derived protein MRP-8/14 are elevated in active multiple sclerosis. Neurosci Lett 247:195-7
5. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M (2005) Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci 29:381-93
6. Chen Y, Ruetzler C, Pandipati S, Spatz M, McCarron RM, Becker K, Hallenbeck JM (2003) Mucosal tolerance to E-selectin provides cell-mediated protection against ischemic brain injury. Proc Natl Acad Sci USA 100: 15107-15112
7. Cheng RY, Birely LA, Lum NL, Perella CM, Cherry JM, Bhat NK, Kasprzak KS, Powell DA, Alvord WG, Anderson LM (2004) Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. J Mol Endocrinol 32:257-78
8. Chung RS, Adlard PA, Dittmann J, Vickers JC, Chuah MI, West AK (2004) Neuron-glia communication - metallothionein expression is specifically up-regulated by astrocytes in response to neuronal injury. J Neurochem 88:454-61
9. Coito AJ, Onodera K, Kato H, Busuttil RW, Kupiec-Weglinski JW (2000) Fibronectin-mononuclear cell interactions regulate type 1 helper T cell cytokine network in tolerant transplant recipients. Am J Pathol 157:1207-18
10. Dempsey RJ, Sailor KA, Bowen KK, Tureyen K, Vemuganti R (2003) Stroke-induced progenitor cell proliferation in adult spontaneously hypertensive rat brain - effect of exogenous IGF-1 and GDNF. J Neurochem 87:586-97
11. Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR, Ceda GP (2004) Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med 117:312-7
12. Emerich DF, Dean III RL, Bartus RT (2002) The role of leukocytes following cerebral ischemia - pathogenic variable or bystander reaction to emerging infarct? Exp Neurol 173:168-81
13. 11C] PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport 11:2957-60
14. Giannakopoulou M, Mansour M, Kazanis E, Bozas E, Philpipidis H, Stylianopoulou F (2000) NMDA receptor mediated changes in IGF-II gene expression in the rat brain after injury and the possible role of nitric oxide. Neuropathol Appl Neurobiol 26:513-21
15. Heinonen KM, Nestel FP, Newell EW, Charette G, Seemayer TA, Tremblay ML, Lapp WS (2004) T-cell protein tyrosine phosphatase deletion results in progressive systemic inflammatory disease. Blood 103:3457-64
16. Hewitt EW (2003) The MHC class I antigen presentation pathway - strategies for viral immune evasion. Immunology 110:163-9
17. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D (2001) Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+) CD25(+) regulatory T cells. J Exp Med 194:847-853
18. Knobeloch KP, Wright MD, Ochsenbein AF, Liesenfeld O, Lohler J, Zinkernagel RM, Horak I, Orinska Z (2000) Targeted inactivation of the tetraspanin CD37 impairs T-cell-dependent B-cell response under suboptimal costimulatory conditions. Mol Cell Biol 20:5363-9
19. Leonard WJ, O'Shea JJ (1998) Jaks and STATs - biological implications. Annu Rev Immunol 16:293-322
20. Liu XF, Fawcett JR, Thorne RG, Frey II WH (2001) Non-invasive intranasal insulin-like growth factor-I reduces infarct volume and improves neurologic function in rats following middle cerebral artery occlusion. Neurosci Lett 308:91-4
21. Martin-Fontecha A, Thomsen LL, Brett S, Gerard C, Lipp M, Lanzavecchia A, Sallusto F (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5:1260-5
22. Meyers JH, Ryu A, Monney L, Nguyen K, Greenfield EA, Freeman GJ, Kuchroo VK (2002) Cutting edge - CD94/NKG2 is expressed on Th1 but not Th2 cells and costimulates Th1 effector functions. J Immunol 169: 5382-6
23. Minton K (2004) T-cell signaling - getting faster with experience. Nat Rev Immunol 4:579
24. Palmiter RD (1998) The elusive function of metallothioneins. Proc Natl Acad Sci USA 95:8428-30
25. Quan N, Stern EL, Whiteside MB, Herkenham M (1999) Induction of pro-inflammatory cytokine mRNAs in the brain after peripheral injection of subseptic doses of lipopolysaccharide in the rat. J Neuroimmunol 93:72-80
26. Ryckman C, Vandal K, Rouleau P, Talbot M, Tessier PA (2003) Proinflammatory activities of S100 - proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 170:3233-42
27. Schabitz WR, Hoffmann TT, Heiland S, Kollmar R, Bardutzky J, Sommer C, Schwab S (2001) Delayed neuroprotective effect of insulin-like growth factor-1 after experimental transient focal cerebral ischemia monitored with MRI. Stroke 32:1226-33
28. Stenzel-Poore MP, Stevens SL, Xiong Z, Lessov NS, Harrington CA, Mori M, Meller R, Rosenzweig HL, Tobar E, Shaw TE, Chu X, Simon RP (2003) Effect of ischaemic preconditioning on genomic response to cerebral ischaemia - similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet 362:1028-37
29. Stinchcombe JC, Bossi G, Booth S, Griffiths GM (2001) The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15:751-61
30. Takeda H, Spatz M, Ruetzler C, McCarron R, Becker K, Hallenbeck J (2002) Induction of mucosal tolerance to E-selectin prevents ischemic and hemorrhagic stroke in SHR-SP rats. Stroke 33:2156-63
31. Valmori D, Merlo A, Souleimanian NE, Hesdorffer CS, Ayyoub M (2005) A peripheral circulating compartment of natural naive CD4 Tregs. J Clin Invest 115:1953-62
32. Vandal K, Rouleau P, Boivin A, Ryckman C, Talbot M, Tessier PA (2003) Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 171:2602-9
33. + T lymphocytes. J Immunol 173:33-41
34. Weiner H (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182:207-14
35. Wiltshire C, Matsushita M, Tsukada S, Gillespie DA, May GH (2002) A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem J 367:577-85
36. Yamadori T, Baba Y, Matsushita M, Hashimoto S, Kurosaki M, Kurosaki T, Kishimoto T, Tsukada S (1999) Bruton's tyrosine kinase activity is negatively regulated by Sab, the Btk-SH3 domain-binding protein. Proc Natl Acad Sci USA 96:6341-6
37. Yamazaki S, Iyoda T, Tarbell K, Olson K, Velinzon K, Inaba K, Steinman RM (2003) Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198:235-47
38. Youssef S, Stuve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, Zamvil SS (2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420:78-84
39. Zhao X, Liu SJ, Zhang J, Strong R, Aronowski J, Grotta JC (2005) Combining insulin-like growth factor derivatives plus caffeinol produces robust neuroprotection after stroke in rats. Stroke 36:129-34